Gene · 7172
Papers3,004
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,004
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinically relevant core genes for hematologic malignancies in clinical NGS panel testing. | Blood Res | 2023 | 37926559 | PubTator, text mining | PubMed |
| Unexpected High Need for Genetic Testing in Rheumatology: A Cross-Sectional Cohort Study. | Genes (Basel) | 2023 | 37895207 | PubTator, text mining | PubMed |
| Implementation of Pharmacogenetics in First-Line Care: Evaluation of Its Use by General Practitioners. | Genes (Basel) | 2023 | 37895189 | PubTator, text mining | PubMed |
| Incidence of Myelotoxicity and Other Adverse Effects Related to Thiopurine Starting in Patients with Inflammatory Bowel Disease: Retrospective Observational Study in a Third-Level Hospital. | J Clin Med | 2023 | 37892708 | PubTator, text mining | PubMed |
| Implications of Tioguanine Dosing in IBD Patients with a TPMT Deficiency. | Metabolites | 2023 | 37887379 | PubTator, text mining | PubMed |
| Experimental pharmacology in precision medicine. | Pharmacol Res Perspect | 2023 | 37885364 | PubTator, text mining | PubMed |
| Classic IgA-Vasculitis With Nephrotic Range Proteinuria - Rare Presentation in an Adult. | J Community Hosp Intern Med Perspect | 2023 | 37877055 | PubTator, text mining | PubMed |
| Sync for Genes Phase 5: Computable artifacts for sharing dynamically annotated FHIR-formatted genomic variants. | Learn Health Syst | 2023 | 37860057 | PubTator, text mining | PubMed |
| Azathioprine dose tailoring based on pharmacogenetic information: Insights of clinical implementation. | Biomed Pharmacother | 2023 | 37857254 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
| Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL. | J Clin Oncol | 2023 | 37820294 | PubTator, text mining | PubMed |
| Constructing and interpreting a large-scale variant effect map for an ultrarare disease gene: Comprehensive prediction of the functional impact of PSAT1 genotypes. | PLoS Genet | 2023 | 37812589 | PubTator, text mining | PubMed |
| The c.415C>T polymorphism in NUDT15 is more frequent than the polymorphisms in TPMT in Chilean patients who use thiopurine drugs. | Pharmacogenet Genomics | 2023 | 37767624 | PubTator, text mining | PubMed |
| Efficacy of Combined Initial Treatment of Methotrexate with Infliximab in Pediatric Crohn's Disease: A Pilot Study. | Biomedicines | 2023 | 37761016 | PubTator, text mining | PubMed |
| Influence of Metabolic, Transporter, and Pathogenic Genes on Pharmacogenetics and DNA Methylation in Neurological Disorders. | Biology (Basel) | 2023 | 37759556 | PubTator, text mining | PubMed |
| Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia. | Front Pharmacol | 2023 | 37745065 | PubTator, text mining | PubMed |
| Risk-stratified monitoring for thiopurine toxicity in immune-mediated inflammatory diseases: prognostic model development, validation, and, health economic evaluation. | EClinicalMedicine | 2023 | 37745026 | PubTator, text mining | PubMed |
| Long-term safety and effectiveness of azathioprine in the management of inflammatory bowel disease: A real-world experience. | JGH Open | 2023 | 37744710 | PubTator, text mining | PubMed |
| Genomic biomarkers: Unveiling the potential for precise cancer therapy response. | Indian J Pharmacol | 2023 | 37737072 | PubTator, text mining | PubMed |
| Identification of potential susceptibility genes in patients with primary Sjögren's syndrome-associated pulmonary arterial hypertension through whole exome sequencing. | Arthritis Res Ther | 2023 | 37730603 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7172/papers?page=13